• Oncoclínicas closed the sale of its full stake in a Saudi joint venture as part of its out-of-court restructuring plan.
• Advanced Drug Company paid USD 6.55 million in full, split between Aug. 10 and Aug. 20.
• Proceeds of BRL 33.32 million are being used to buy medicines under the extrajudicial recovery plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.